Ocoee Pediatrics of Cleveland, PC
Ocoee Pediatrics of Cleveland, PC was paid $6.09M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 96110, Developmental screening, with scoring and documentation, per standardized instrument — 18% of everything it billed.
33Billing provider infoOCOEE PEDIATRICS OF CLEVELAND, PC
CLEVELAND, TN 37312
CLEVELAND, TN 37312
33aNPI1174911838assigned 01/05/2015
33bProvider typeSpecialist
28Total paid$6.09M
24GClaims254,020
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#7 of 252
Median peer was paid$57K
This provider vs. median107×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,150 | $201K | |
| 2019 | 27,564 | $577K | |
| 2020 | 27,952 | $609K | |
| 2021 | 44,869 | $1.04M | |
| 2022 | 47,591 | $1.10M | |
| 2023 | 52,142 | $1.33M | |
| 2024incomplete | 44,752 | $1.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 18% | 32,686 | 17,988 | $1.07M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 26,223 | 23,392 | $1.02M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 12,065 | 10,916 | $728K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.6% | 19,990 | 9,259 | $523K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.2% | 7,173 | 6,178 | $501K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.1% | 6,254 | 5,289 | $373K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.7% | 4,166 | 3,753 | $285K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.8% | 4,730 | 4,365 | $233K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 24,752 | 21,192 | $222K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 5,237 | 4,827 | $167K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.6% | 1,473 | 1,185 | $157K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 12,640 | 5,787 | $156K |
53 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 9,717 | $116K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 4,011 | $104K |
| 99173 | 1.1% | 8,940 | $67K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 853 | $64K |
| 36416 | <1% | 25,316 | $58K | |
| 92558 | <1% | 6,694 | $42K | |
| 96127 | <1% | 5,932 | $27K | |
| 83655 | <1% | 1,792 | $25K | |
| 80061 | Lipid panel | <1% | 1,609 | $23K |
| 81002 | <1% | 7,313 | $21K | |
| 87807 | <1% | 1,578 | $18K | |
| 87631 | <1% | 119 | $17K | |
| 96161 | <1% | 1,112 | $12K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 112 | $11K |
| 81003 | <1% | 3,781 | $8K | |
| 96160 | <1% | 299 | $6K | |
| 99381 | <1% | 89 | $6K | |
| 92551 | <1% | 805 | $5K | |
| 90670 | <1% | 2,608 | $4K | |
| 86308 | <1% | 901 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 90 | $4K |
| 90461 | <1% | 4,481 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 710 | $2K |
| 92587 | <1% | 37 | $1K | |
| 99401 | <1% | 52 | $1K | |
| 99383 | <1% | 13 | $1K | |
| 90716 | <1% | 507 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 29 | $876.07 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 48 | $806.44 |
| 90633 | <1% | 926 | $608.30 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $601.15 |
| 90707 | <1% | 583 | $583.41 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 67 | $527.39 |
| 99442 | <1% | 12 | $443.75 | |
| 90648 | <1% | 2,128 | $359.24 | |
| 90734 | <1% | 54 | $331.22 | |
| 94760 | <1% | 56 | $326.27 | |
| 90677 | <1% | 307 | $321.61 | |
| 90686 | <1% | 213 | $318.19 | |
| 90651 | <1% | 84 | $294.18 | |
| 90696 | <1% | 80 | $135.64 | |
| 90715 | <1% | 43 | $118.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 59 | $66.58 |
| 82270 | <1% | 19 | $46.67 | |
| 90700 | <1% | 25 | $31.90 | |
| 90688 | <1% | 133 | $21.47 | |
| 90681 | 0% | 152 | $0.00 | |
| 90671 | 0% | 22 | $0.00 | |
| 90658 | 0% | 13 | $0.00 | |
| 90723 | 0% | 1,186 | $0.00 | |
| 90680 | 0% | 249 | $0.00 | |
| 90697 | 0% | 465 | $0.00 | |
| 99000 | 0% | 192 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEFRIECE, LISA (BILLING SUPERVISOR)